These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 18854336

  • 1. Adenoviral activin A expression prevents vein graft intimal hyperplasia in a rat model.
    Kloppenburg GT, Grauls GE, Bruggeman CA, Stassen FR.
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):31-4. PubMed ID: 18854336
    [Abstract] [Full Text] [Related]

  • 2. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
    Hata JA, Petrofski JA, Schroder JN, Williams ML, Timberlake SH, Pippen A, Corwin MT, Solan AK, Jakoi A, Gehrig TR, Kontos CD, Milano CA.
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
    [Abstract] [Full Text] [Related]

  • 3. Antisense to transforming growth factor-beta(1) facilitates the apoptosis of macrophages in rat vein grafts.
    Heaton NS, Wolff RA, Malinowski RL, Hullett DA, Hoch JR.
    J Vasc Res; 2008 Jun; 45(5):365-74. PubMed ID: 18354256
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antisense to transforming growth factor-beta1 messenger RNA reduces vein graft intimal hyperplasia and monocyte chemotactic protein 1.
    Wolff RA, Ryomoto M, Stark VE, Malinowski R, Tomas JJ, Stinauer MA, Hullett DA, Hoch JR.
    J Vasc Surg; 2005 Mar; 41(3):498-508. PubMed ID: 15838486
    [Abstract] [Full Text] [Related]

  • 6. Adenoviral activin a expression prevents intimal hyperplasia in human and murine blood vessels by maintaining the contractile smooth muscle cell phenotype.
    Engelse MA, Lardenoye JH, Neele JM, Grimbergen JM, De Vries MR, Lamfers ML, Pannekoek H, Quax PH, De Vries CJ.
    Circ Res; 2002 May 31; 90(10):1128-34. PubMed ID: 12039804
    [Abstract] [Full Text] [Related]

  • 7. The role of RAGE in aminoguanidine-induced suppression of venous intimal hyperplasia in diabetic rats.
    Wang X, Diao Y, Zhang H, Huo X, Zhang Q.
    Ann Vasc Surg; 2009 Mar 31; 23(2):246-54. PubMed ID: 19110400
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model.
    Miyake T, Aoki M, Shiraya S, Tanemoto K, Ogihara T, Kaneda Y, Morishita R.
    J Mol Cell Cardiol; 2006 Sep 31; 41(3):431-40. PubMed ID: 16762361
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor-beta1 antisense treatment of rat vein grafts reduces the accumulation of collagen and increases the accumulation of h-caldesmon.
    Wolff RA, Malinowski RL, Heaton NS, Hullett DA, Hoch JR.
    J Vasc Surg; 2006 May 31; 43(5):1028-36. PubMed ID: 16678700
    [Abstract] [Full Text] [Related]

  • 13. Reduced neointima in vein grafts following a blockage of cell recruitment from the vein and the surrounding tissue.
    Fogelstrand P, Osterberg K, Mattsson E.
    Cardiovasc Res; 2005 Aug 01; 67(2):326-32. PubMed ID: 15885671
    [Abstract] [Full Text] [Related]

  • 14. The temporal sequence of G-protein expression in intimal hyperplasia.
    Davies MG, Barber L, Dhanraj DN, Gettys TW, Ramkumar V, Hagen PO.
    J Surg Res; 1996 Jun 01; 63(1):115-22. PubMed ID: 8661183
    [Abstract] [Full Text] [Related]

  • 15. Clinical protocol. A phase IIb, randomized, multicenter, double-blind study of the efficacy and safety of Trinam (EG004) in stenosis prevention at the graft-vein anastomosis site in dialysis patients.
    Fuster V, Charlton P, Boyd A.
    Hum Gene Ther; 2001 Nov 01; 12(16):2025-7. PubMed ID: 11727735
    [Abstract] [Full Text] [Related]

  • 16. Effect of AP-1 decoy using hemagglutinating virus of Japan-liposome on the intimal hyperplasia of the autogenous vein graft in mongrel dogs.
    Cho WH, Kim HT, Koo JH, Lee IK.
    Transplant Proc; 2006 Sep 01; 38(7):2161-3. PubMed ID: 16980031
    [Abstract] [Full Text] [Related]

  • 17. The new immunosuppressive agent FK778 attenuates neointima formation in an experimental venous bypass graft model.
    de Graaf R, Kloppenburg G, Tintu A, Rouwet E, Kitslaar P, van Hooff J, Bruggeman C, Stassen F.
    Vascul Pharmacol; 2009 Sep 01; 50(3-4):83-8. PubMed ID: 19010449
    [Abstract] [Full Text] [Related]

  • 18. FK778 attenuates cytomegalovirus-enhanced vein graft intimal hyperplasia in a rat model.
    Kloppenburg G, de Graaf R, Grauls G, Bruggeman CA, van Hooff JP, Stassen F.
    Intervirology; 2009 Sep 01; 52(4):189-95. PubMed ID: 19546576
    [Abstract] [Full Text] [Related]

  • 19. A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
    Petrofski JA, Hata JA, Williams ML, Parsa CJ, Thompson RB, Hanish SI, Gehrig TR, Koch WJ, Milano CA.
    J Thorac Cardiovasc Surg; 2005 Dec 01; 130(6):1683-90. PubMed ID: 16308016
    [Abstract] [Full Text] [Related]

  • 20. Vein adaptation to arterialization in an experimental model.
    Westerband A, Crouse D, Richter LC, Aguirre ML, Wixon CC, James DC, Mills JL, Hunter GC, Heimark RL.
    J Vasc Surg; 2001 Mar 01; 33(3):561-9. PubMed ID: 11241128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.